https://www.selleckchem.com/pr....oducts/alpha-conotox
90 95% CI 3.04-7.88; p 0.00001), cereborovascular disease (RR 4.78; 95% CI 3.39-6.76; p 0.00001), cardiovascular disease (RR 3.05 95% CI 2.20-4.25; p 0.00001), respiratory disease (RR 2.74 95% CI 2.04-3.67; p 0.00001), diabetes (RR 1.97 95% CI 1.48-2.64; p 0.00001), hypertension (RR 1.95 95% CI 1.58-2.40; p 0.00001), and cancer (RR 1.89; 95% CI 1.25-2.84; p = 0.002) but not liver disease (RR 1.64 95% CI 0.82-3.28; p= 0.16). Implementation of adequate protection and interventions for COVID-19 pati
Like
Comment
Share
